Copyright
©2006 Baishideng Publishing Group Co.
World J Gastroenterol. Jan 14, 2006; 12(2): 199-203
Published online Jan 14, 2006. doi: 10.3748/wjg.v12.i2.199
Published online Jan 14, 2006. doi: 10.3748/wjg.v12.i2.199
Figure 1 Illustrated interaction between the cadherin–catenin complex and the APC protein.
(A) In the absence of Wnt-1 and the presence of glycogen synthase kinase (GSK), β-catenin (β-cat) is stabilized and bound to cadherin or APC protein. Cadherin acts as a negative regulator of β-catenin by regulating the amount of free β-catenin. The free cytoplasmic β-catenin is degraded. (B) In the presence of Wnt-1, GSK is antagonized and mutant APC or tyrosine phosphorylated β-catenin cannot bind to each other, cytosolic free β-catenin concentrations rise, which leads to down-stream cell signalling and may be involved in carcinogenesis.
- Citation: Chan AOO. E-cadherin in gastric cancer. World J Gastroenterol 2006; 12(2): 199-203
- URL: https://www.wjgnet.com/1007-9327/full/v12/i2/199.htm
- DOI: https://dx.doi.org/10.3748/wjg.v12.i2.199